A Canadian study found that giving ICU patients the amino acid glutamine in intravenous fluids raised their risk of death by 30%, and that replacing antioxidants did not reduce the likelihood of death or organ failure. The study, published in the New England Journal of Medicine, included 1,223 patients with multi-organ failure in 40 ICUs in the U.S., Canada and Europe.
Study: Nutrition therapy may raise mortality risk in ICU patients
SmartBrief Job Listings for Health Care
|NGS Provider Enrollment Rep||
National Government Services - WellPoint
|Program Manager II||
Tufts Health Plan/Network Health
|Director, Medicare Advantage/Medicare Part D Focus||
|Chief, Product Review Branch||
FDA/Center for Biologics Evaluation and Research
|Silver Spring, MD|
|Director of Clinical Research||
Regenesis Biomedical, Inc.